- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02334228
Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness
January 7, 2015 updated by: Dartmouth-Hitchcock Medical Center
Promoting Health and Functioning in Persons With SMI
Few studies targeting obesity in serious mental illness have reported clinically significant risk reduction, and non have been replicated in community settings or demonstrated sustained outcomes after intervention withdrawal.
The researchers sought to replicate positive health outcomes demonstrated in a previous randomized effectiveness study of the In SHAPE program across urban community mental health organizations serving an ethnically diverse population.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In this randomized, controlled study, 133 adults age 21 and older with serious mental illness (SMI) and poor physical fitness (BMI>25, or <10 minutes of exercise 2x over the past month) were randomized to either: a) In SHAPE Lifestyles (ISL) intervention or b) Health Club Membership and Education (HCME): consisting of a YMCA membership, educational materials on exercise and healthy diet, and an on-site introduction to the health club.
The following three specific aims were addressed: 1) To compare ISL and HCME with respect to: a) participation in regular exercise and dietary change; (b) participation in preventive health care; and (c) improved fitness and health; (2) to compare ISL and HCME with respect to: (a) indicators of mental health and (b) personal self-efficacy; and (3) to explore differences in ISL and HCME with respect to (a) selected physical, metabolic, dietary, and community functioning secondary outcomes; and (b) the relationship of demographic variables and readiness to change to outcomes.
ISL participants received a 6-month intensive program of one-to-one health mentoring, followed by a 3-month period of transitioning to self-directed individual and group programming, with assessments conducted at baseline, 3, 6, 9, and 12 months.
If found to be effective, ISL will provide a practical approach to improving health, independent functioning, and longevity in disabled persons with SMI.
Study Type
Interventional
Enrollment (Actual)
133
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Concord, New Hampshire, United States, 03301
- Riverbend Community Mental Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 21 or older
- Serious mental illness defined by an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia
- Persistent impairment in multiple areas of functioning (e.g., work, school, self-care)
- Body mass index (BMI) greater than 25
- Able and willing to provide informed consent
- On stable pharmacological treatment (same psychiatric medications over prior 2 months)
Exclusion Criteria:
- Residing in a nursing home of other institution
- Diagnosis of dementia or significant cognitive impairment (MMSE<24)
- Unable to walk one city block
- Pregnant or planning to become pregnant within the next 18 months
- Unable to speak English
- Terminal illness with life expectancy <1 year
- Current diagnosis of an active substance dependence disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: In SHAPE Lifestyles
In SHAPE Lifestyle is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.
|
In SHAPE Lifestyles is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.
|
|
Active Comparator: Health Club Membership and Education
Fitness club membership with education in using the exercise equipment.
|
Fitness club membership with education in using the exercise equipment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Exercise Capacity
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in fitness as measured by the 6-minute walk test.
|
Baseline, 3-, 6-, 9-, and 12-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
|
Change in Weight
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in weight over time was measured at baseline, 3-, 6-, 9-, and 12-months.
Measures were weight (lbs).
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Triglycerides and Cholesterol
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in triglycerides and cholesterol measured with the CardioChek PA Analyzer: Fasting blood glucose and lipids.
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Health Status
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in health status was measured by the SF-12: Medical Outcomes Study Short Form -12
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Community Functioning
Time Frame: Baseline, 9-, and 12-months
|
Change in community functioning was measured by the ILSS: Independent Living Skills Scale
|
Baseline, 9-, and 12-months
|
|
Change in Physical Measurements (Fitness)
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change is physical measurements was determined by measuring waist circumference and resting pulse
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Psychological State
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in psychological state was measured using the CESD: Cntr Epid Studies Dep; SANS: Scale Assess Neg Sx; R-SES: Revised Self-efficacy Scale
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Participation in Exercise
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in participation in exercise was determined by measuring weekly exercise at 3-, 6-, 9-, and 12-months using a physical activity log; weekly health club attendance at 3-, 6-, 9-, and 12-months based on frequency of YMCA visits; total physical activity at baseline, 3-, 6-, 9-, and 12-months based on the YPAS: Yale Physical Activity Scale.
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Diet Behaviors
Time Frame: Baseline, 3-, 6-, 9-, and 12-months
|
Change in diet behaviors was measured based on the WLB-SOC: Weight Loss Behavior State of Change Scale.
|
Baseline, 3-, 6-, 9-, and 12-months
|
|
Change in Preventative Health Care
Time Frame: Baseline and 12-months
|
Change in preventative health care was based on the PHC: Preventative Healthcare Checklist
|
Baseline and 12-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stephen J Bartels, MD,MS, Dartmouth-Hitchcock Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2006
Primary Completion (Actual)
August 1, 2009
Study Completion (Actual)
August 1, 2009
Study Registration Dates
First Submitted
January 6, 2015
First Submitted That Met QC Criteria
January 7, 2015
First Posted (Estimate)
January 8, 2015
Study Record Updates
Last Update Posted (Estimate)
January 8, 2015
Last Update Submitted That Met QC Criteria
January 7, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Concord InSHAPE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Recruiting
-
Bradley LegaRecruiting
Clinical Trials on In SHAPE Lifestyles
-
Dartmouth-Hitchcock Medical CenterCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderUnited States
-
Dartmouth-Hitchcock Medical CenterRobert Wood Johnson Foundation; Endowment for HealthCompletedMental IllnessUnited States
-
Universidad de ZaragozaCompleted
-
Fonterra Research CentreSprim Advanced Life SciencesCompleted
-
University of WashingtonKaiser PermanenteCompletedOsteoarthritis | Sleep Disturbance | Pain DysfunctionUnited States
-
Bronx-Lebanon Hospital Center Health Care SystemUnitedHealthcare FoundationUnknownChildhood ObesityUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedDevelopmental Disabilities | Mental Retardation | Intellectual DisabilitiesUnited States
-
Brigham and Women's HospitalJohns Hopkins University; Case Western Reserve University; Partners HealthCare; VA Boston Healthcare SystemCompletedCoronary Artery Disease | Cardiovascular Disease | Obstructive Sleep ApneaUnited States
-
The First Hospital of Jilin UniversityNot yet recruitingLiver Neoplasms | Colorectal Neoplasms | Colorectal Liver Metastasis